HONOLULU – The Hawai‘i Department of Health announces scheduling opportunities for the COVID-19 vaccine manufactured by Novavax.

Novavax is a two-dose primary series vaccine for individuals 18 and older. The Centers for Disease Control and Prevention recommends administering the second dose three to eight weeks after the first.

Novavax is a protein subunit vaccine. It includes harmless proteins of the COVID-19 virus that trigger an immune response.

Protein subunit vaccines, which include vaccines for hepatitis B, whooping cough, shingles, and other diseases, have been used in the United States for more than 30 years.

“Novavax gives us another way to protect ourselves from COVID-19. Its arrival is great news for people who are allergic to an ingredient in the mRNA vaccines manufactured by Pfizer and Moderna or those who, for whatever reason, have been reluctant to be vaccinated,” said State Health Director Dr. Elizabeth Char, FACEP.

5 Minute Pharmacy on O‘ahu and Safeway Pharmacy in Kailua-Kona on Hawaii Island offer Novavax vaccinations. Scheduling information for 5 Minute Pharmacy and the Kailua-Kona Safeway is available on the vaccination map at hawaiicovid19.com/vaccine.

Kaiser Permanente is also offering Novavax in all counties to members and non-members starting Aug. 15, 2022 by appointment only. Appointments can be made by calling 808-432-2000.

# # #

PDF: Novavax COVID-19 vaccine available in Hawai‘i

Categories: News Releases, Vaccine
Recent Posts

Hawai‘i COVID-19 hospitalizations on the rise

HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]

Wastewater Samples Show Higher COVID Concentrations & New Subvariant

The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]

Bivalent boosters for keiki as young as 6 months

Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]

Select Archive Month